AU2013293350B2 - Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad - Google Patents

Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad Download PDF

Info

Publication number
AU2013293350B2
AU2013293350B2 AU2013293350A AU2013293350A AU2013293350B2 AU 2013293350 B2 AU2013293350 B2 AU 2013293350B2 AU 2013293350 A AU2013293350 A AU 2013293350A AU 2013293350 A AU2013293350 A AU 2013293350A AU 2013293350 B2 AU2013293350 B2 AU 2013293350B2
Authority
AU
Australia
Prior art keywords
eur
spinosad
formulation
cat
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2013293350A
Other languages
English (en)
Other versions
AU2013293350A1 (en
Inventor
Kari Lynette Riggs
Daniel Earl Snyder
Michelle Leigh TOTTEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2013293350A1 publication Critical patent/AU2013293350A1/en
Application granted granted Critical
Publication of AU2013293350B2 publication Critical patent/AU2013293350B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/34—Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/22—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N2300/00—Combinations or mixtures of active ingredients covered by classes A01N27/00 - A01N65/48 with other active or formulation relevant ingredients, e.g. specific carrier materials or surfactants, covered by classes A01N25/00 - A01N65/48

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2013293350A 2012-07-26 2013-07-18 Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad Ceased AU2013293350B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261676023P 2012-07-26 2012-07-26
US61/676,023 2012-07-26
PCT/US2013/050987 WO2014018352A1 (en) 2012-07-26 2013-07-18 Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad

Publications (2)

Publication Number Publication Date
AU2013293350A1 AU2013293350A1 (en) 2015-02-05
AU2013293350B2 true AU2013293350B2 (en) 2015-07-23

Family

ID=48877579

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013293350A Ceased AU2013293350B2 (en) 2012-07-26 2013-07-18 Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad

Country Status (14)

Country Link
US (2) US9220719B2 (enExample)
EP (1) EP2877005A1 (enExample)
JP (1) JP2015523388A (enExample)
KR (1) KR20150023831A (enExample)
CN (1) CN104703474A (enExample)
AR (1) AR091769A1 (enExample)
AU (1) AU2013293350B2 (enExample)
BR (1) BR112015001152A2 (enExample)
CA (1) CA2878009A1 (enExample)
EA (1) EA201590097A1 (enExample)
IN (1) IN2014MN02599A (enExample)
MX (1) MX2015001137A (enExample)
TW (1) TW201416077A (enExample)
WO (1) WO2014018352A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018183512A1 (en) * 2017-03-28 2018-10-04 Piedmont Animal Health, Llc Combinations of acaricides and insect growth regulators for control of fleas without emesis in animals
WO2020012406A1 (en) * 2018-07-11 2020-01-16 Jubilant Generics Limited Veterinary dosage forms
CN118055703A (zh) * 2021-06-25 2024-05-17 碗中动物健康公司 猫科动物口服饲料和在猫科动物中控制蚤侵袭的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001011963A1 (en) * 1999-08-12 2001-02-22 Eli Lilly And Company Oral treatment of companion animals with ectoparasiticidal spinosyns
EP2248422A1 (en) * 2009-05-08 2010-11-10 Novartis AG Ectoparasiticidal compositions
WO2012061807A1 (en) * 2010-11-05 2012-05-10 Eli Lilly And Company Methods for inhibiting insect infestations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100904941B1 (ko) * 2001-03-21 2009-06-29 다우 아그로사이언시즈 엘엘씨 살충성 스피노신 유도체
US20080311191A1 (en) * 2004-08-27 2008-12-18 Avinash Nangia Multi-Layer Tablets and Bioadhesive Dosage Forms
US20070149464A1 (en) * 2005-06-15 2007-06-28 Pfizer Inc. Combination
US20120003661A1 (en) 2010-07-05 2012-01-05 C3 Jian, Inc. Methods and devices for the selective detection of microorganisms

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001011963A1 (en) * 1999-08-12 2001-02-22 Eli Lilly And Company Oral treatment of companion animals with ectoparasiticidal spinosyns
EP2248422A1 (en) * 2009-05-08 2010-11-10 Novartis AG Ectoparasiticidal compositions
WO2012061807A1 (en) * 2010-11-05 2012-05-10 Eli Lilly And Company Methods for inhibiting insect infestations

Also Published As

Publication number Publication date
EP2877005A1 (en) 2015-06-03
AU2013293350A1 (en) 2015-02-05
BR112015001152A2 (pt) 2017-06-27
US20140031306A1 (en) 2014-01-30
JP2015523388A (ja) 2015-08-13
CN104703474A (zh) 2015-06-10
EA201590097A1 (ru) 2015-06-30
AR091769A1 (es) 2015-02-25
MX2015001137A (es) 2015-10-14
IN2014MN02599A (enExample) 2015-07-24
WO2014018352A1 (en) 2014-01-30
CA2878009A1 (en) 2014-01-30
US20160101127A1 (en) 2016-04-14
TW201416077A (zh) 2014-05-01
KR20150023831A (ko) 2015-03-05
US9220719B2 (en) 2015-12-29

Similar Documents

Publication Publication Date Title
AU775488B2 (en) Oral treatment of companion animals with ectoparasiticidal spinosyns
US9220719B2 (en) Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad
US11375717B2 (en) Combinations of acaricides and insect growth regulators for control of fleas without emesis in animals
US20230413818A1 (en) Feed and methods for controlling tick infestations in a mammal
EP4523685B1 (en) Dihydroisoxazole compound for use in the treatment of ectoparasite infestations on fish
US20230414644A1 (en) Oral canine feed and methods for controlling flea infestations in a canine
US20240138442A1 (en) Oral feline feed and methods for controlling flea infestations in a feline

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired